Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Antoniou

Showing results (231-240 of 395) with videos related to

Pageof 40
Sort By:
European Urology|June 14, 2020
Prostate Cancer Risk by BRCA2 Genomic RegionsTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
European Urology|September 10, 2019
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort StudyTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
The Lancet Regional Health. Western Pacific|February 9, 2024
Age-specific breast and ovarian cancer risks associated with germline <i>BRCA1</i> or <i>BRCA2</i> pathogenic variants - an Asian study of 572 familiesWeang-Kee Ho, Nur Tiara Hassan, Sook-Yee Yoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2022
Predicting the Likelihood of Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation in Asian Patients With Breast CancerBoon Hong Ang, Weang Kee Ho, Eldarina Wijaya, et al.
Nature Reviews. Clinical Oncology|July 1, 2020
Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
British Journal of Cancer|March 20, 2008
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsA C Antoniou, A P Cunningham, J Peto, et al.
Journal of the National Cancer Institute|April 2, 2025
A randomized study of 2 risk assessment models for individualized breast cancer risk estimationAdrià López-Fernández, Laura Duran-Lozano, Guillermo Villacampa, et al.
Nature Reviews. Clinical Oncology|June 20, 2020
Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
Cancers|June 19, 2024
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and OpportunitiesMeghan J Walker, Kristina M Blackmore, Amy Chang, et al.
Journal of the National Cancer Institute|May 1, 2013
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACENasim Mavaddat, Susan Peock, Debra Frost, et al.
Pageof 40

Showing results (231-240 of 395) with videos related to

Sort By:
Pageof 40
European Urology|June 14, 2020
Prostate Cancer Risk by BRCA2 Genomic RegionsTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
European Urology|September 10, 2019
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort StudyTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
The Lancet Regional Health. Western Pacific|February 9, 2024
Age-specific breast and ovarian cancer risks associated with germline <i>BRCA1</i> or <i>BRCA2</i> pathogenic variants - an Asian study of 572 familiesWeang-Kee Ho, Nur Tiara Hassan, Sook-Yee Yoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2022
Predicting the Likelihood of Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation in Asian Patients With Breast CancerBoon Hong Ang, Weang Kee Ho, Eldarina Wijaya, et al.
Nature Reviews. Clinical Oncology|July 1, 2020
Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
British Journal of Cancer|March 20, 2008
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsA C Antoniou, A P Cunningham, J Peto, et al.
Journal of the National Cancer Institute|April 2, 2025
A randomized study of 2 risk assessment models for individualized breast cancer risk estimationAdrià López-Fernández, Laura Duran-Lozano, Guillermo Villacampa, et al.
Nature Reviews. Clinical Oncology|June 20, 2020
Personalized early detection and prevention of breast cancer: ENVISION consensus statementNora Pashayan, Antonis C Antoniou, Urska Ivanus, et al.
Cancers|June 19, 2024
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and OpportunitiesMeghan J Walker, Kristina M Blackmore, Amy Chang, et al.
Journal of the National Cancer Institute|May 1, 2013
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACENasim Mavaddat, Susan Peock, Debra Frost, et al.
Pageof 40